Advertisement

Endocrine

, Volume 60, Issue 2, pp 255–262 | Cite as

Complete evaluation of pituitary tumours in a single tertiary care institution

  • Dimitrios Askitis
  • Damianos Tsitlakidis
  • Nicolle Müller
  • Albrecht Waschke
  • Gunter Wolf
  • Ulrich Alfons Müller
  • Christof Kloos
Endocrine Surgery

Abstract

Introduction

We retrospectively evaluated all patients with pituitary tumours treated in our department from 1/1/1997 to 01/11/2014.

Patients and methods

Two hundred and fifteen patients (124 females, 91 males, mean age 50.9 years) were treated because of pituitary tumours. All patients underwent basal hormonal analysis and when required dynamic testing in order to check for hormonal activity. Pituitary masses were divided into groups concerning their hormonal status and were further classified according to gender, age at diagnosis, tumour size, and the development of postoperative pituitary insufficiency when neurosurgical intervention was conducted.

Results

One hundred and twenty-one patients had hormonally inactive tumours (non-functional adenomas; 56.3%), 57 prolactinomas (26.5%), 17 growth hormone secreting adenomas (7.9%), 16 Cushing’s disease (7.4%), and 4 craniopharyngiomas (1.9%). Tumours with maximum size <1 cm (microadenomas) were detected in 62 patients (28.8%) and ≥1 cm (macroadenomas) in 153 (71.2%) of all cases (rate 1:2.5). Ninty eight patients (45.6%) had surgery (87 transsphenoidal and 11 transcranial), of this group 34 with hormonally active tumours (37.8% of the 90 patients of this subcohort). Indications for surgery were an increased risk or manifestation of chiasma syndrome and clinical symptoms due to hormonal hypersecretion. Complete [32 cases (32.6%)] or partial [33 cases (33.7%)] postoperative insufficiency in minimum one pituitary axis was present in 65/98 (66.3%) of the operated patients.

Conclusions

Pituitary adenoma prevalence is rising due to widely available imaging procedures. The majority of the tumours in our cohort were macroadenomas and hormonally inactive. Tumour extirpation via the transsphenoidal or transcranial route resulted in functional pituitary impairment of variable extent in 2/3 of the patients.

Keywords

Pituitary tumours Epidemiology Thuringia 

Notes

Acknowledgements

Authors thank Department of Pathology, University of Jena, University Hospital Jena for its valuable help in assessing pituitary surgical specimens.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study and the Regional Ethical Committee approved the study.

References

  1. 1.
    S.L. Asa, Tumors of the Pituitary Gland (Armed Forces Institute of Pathology, Washington, DC, 1998)Google Scholar
  2. 2.
    H. Buurman, W. Saeger, Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur. J. Endocrinol. 154, 753–758 (2006)CrossRefPubMedGoogle Scholar
  3. 3.
    V. Vasilev, L. Rostomyan, A.F. Daly, I. Potorac, S. Zacharieva, J.F. Bonneville, A. Beckers, MANAGEMENT OF ENDOCRINE DISEASE: pituitary ‘incidentaloma’: neuroradiological assessment and differential diagnosis. Eur. J. Endocrinol. 175(4), R171–R184 (2016)CrossRefPubMedGoogle Scholar
  4. 4.
    C. Muhr, K. Bergstrom, L. Grimelius, S.G. Larsson, A parallel study of the roentgen anatomy of the sella turcica and the histopathology of the pituitary gland in 205 autopsy specimens. Neuroradiology 21, 55–65 (1981)CrossRefPubMedGoogle Scholar
  5. 5.
    A. Teramoto, K. Hirakawa, N. Sanno, Y. Osamura, Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 193, 161–164 (1994)CrossRefPubMedGoogle Scholar
  6. 6.
    G.N. Burrow, G. Wortzman, N.B. Rewcastle, R.C. Holgate, K. Kovacs, Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N. Engl. J. Med. 304, 156–158 (1981)CrossRefPubMedGoogle Scholar
  7. 7.
    T. Tomita, E. Gates, Pituitary adenomas and granular cell tumors: incidence, cell type, and location of tumor in 100 pituitary glands at autopsy. Am. J. Clin. Pathol. 111, 817–825 (1999)CrossRefPubMedGoogle Scholar
  8. 8.
    S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas. Cancer 101, 613–619 (2004)CrossRefPubMedGoogle Scholar
  9. 9.
    R.M. Chidiac, D.C. Aron, Incidentalomas: a disease of modern technology. Endocrinol. Metab. Clin. North Am. 26, 233–253 (1997)CrossRefPubMedGoogle Scholar
  10. 10.
    M.E. Molitch, E.J. Russell, The pituitary ‘incidentaloma’. Ann. Intern. Med. 112, 925–931 (1990)CrossRefPubMedGoogle Scholar
  11. 11.
    W.A. Hall, M.G. Luciano, J.L. Doppman, N.J. Patronas, E.H. Oldfield, Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann. Intern. Med. 120, 817–820 (1994)CrossRefPubMedGoogle Scholar
  12. 12.
    B.W. Chong, W. Kucharczyk, W. Singer, S. George, Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. Am. J. Neuroradiol. 15, 675–679 (1994)PubMedGoogle Scholar
  13. 13.
    Y. Greenman, N. Stern, Non-functioning pituitary adenomas. Best Pract. Res. Clin. Endocrinol. Metab. 23, 625–638 (2009)CrossRefPubMedGoogle Scholar
  14. 14.
    C.A. Jaffe, Clinically non-functioning pituitary adenoma. Pituitary 9, 317–321 (2006)CrossRefPubMedGoogle Scholar
  15. 15.
    R.J. Lloyd, K. Kovacs, W.F. Young Jr., W.E. Farrell, S.L. Asa, J. Trouillas, G. Kontogeorgos, T. Sano, B.W. Scheithauer, E. Horvath, R.E. Watson Jr., E.P. Lindell, A.L. Barkan, W. Saeger, V. Nose, R.Y. Osamura, S. Ezzat, S. Yamada, F. Roncaroli, M.B.S. Lopes, S. Vidal Ruibal, in Pathology and Genetics of Tumours of Endocrine Organs, ed. by R.A. DeLellis, R.V. Lloyd, P.U. Heitz (International Agency for Research and Cancer (IARC), Lyon, 2004), pp. 9–48Google Scholar
  16. 16.
    W. Saeger, D. Luebke, Pituitary carcinoma: a review. Endocr. Pathol. 7, 21–35 (1996)CrossRefPubMedGoogle Scholar
  17. 17.
    A. Raappana, J. Koivukangas, T. Ebeling, T. Pirila, Incidence of pituitary adenomas in northern Finland in 1992–2007. J. Clin. Endocrinol. Metab. 95, 4268–4275 (2010)CrossRefPubMedGoogle Scholar
  18. 18.
    M. Gruppetta, C. Mercieca, J. Vassallo, Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary 16, 545–553 (2013)CrossRefPubMedGoogle Scholar
  19. 19.
    A. Tjörnstrand, K. Gunnarsson, M. Evert, E. Holmberg, O. Ragnarsson, T. Rosén, H. Filipsson Nyström, The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011. Eur. J. Endocrinol. 171, 519–526 (2014)Google Scholar
  20. 20.
    A.F. Daly, M. Rixhon, C. Adam et al., High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91, 4769–4775 (2006)CrossRefPubMedGoogle Scholar
  21. 21.
    A. Fernandez, N. Karavitaki, J.A.H. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72, 377–382 (2010)CrossRefGoogle Scholar
  22. 22.
    T.T. Agustsson, T. Baldvinsdottir, J.G. Jonasson, E. Olafsdottir, V. Steinthorsdottir, G. Sigurdsson, A.V. Thorsson, P.V. Carroll, M. Korbonits, R. Benediktsson, The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur. J. Endocrinol. 173, 655–664 (2015)Google Scholar
  23. 23.
    D.J. McComb, N. Ryan, E. Horvath, K. Kovacs, Subclinical adenomas of the human pituitary: new light on old problems. Arch. Pathol. Lab. Med. 107, 488–491 (1983)PubMedGoogle Scholar
  24. 24.
    B. Ambrosi, G. Faglia, Multicenter Pituitary Study Group, in Pituitary Adenomas. New Trends in Basic and Clinical Research. Proceedings of the 5th European Workshop on Pituitary Adenomas, Venice, ed. by G. Faglia, P. Beck-Peccoz, B. Ambrosi, P. Travaglini, A. Spada (Excerpta Medica, Amsterdam, 1991), pp. 159–168Google Scholar
  25. 25.
    E.B. Gold, Epidemiology of pituitary adenomas. Epidemiol. Rev. 3, 182 (1981)CrossRefGoogle Scholar
  26. 26.
    K. Radhakrishnan, B. Mokri, J.E. Parisi, W.M. O’Fallon, J. Sunku, L.T. Kurland, The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann. Neurol. 37, 67–73 (1995).CrossRefPubMedGoogle Scholar
  27. 27.
    J.R. Davis, W.E. Farrell, R.N. Clayton, Pituitary tumours. Reproduction 121, 363–371 (2001)Google Scholar
  28. 28.
    B.W. Scheithauer, O. Kurtkaya-Yapicier, K.T. Kovacs, W.F. Young Jr., R.V. Lloyd, Pituitary carcinoma: a clinicopathological review. Neurosurgery 56, 1066–1074 (2005)Google Scholar
  29. 29.
    J. Trouillas, C. Girod, in Pituitary Adenomas, ed. by A.M. Landolt, M.L. Vance, P.L. Reilly (Churchill Livingstone, Edinburgh, 1996), pp. 27–46Google Scholar
  30. 30.
    P. Anagnostis, F. Adamidou, S.A. Polyzos, Z. Efstathiadou, A. Panagiotou, M. Kita, Pituitary incidentalomas: a single-centre experience. Int. J. Clin. Pract. 65, 172–177 (2011)CrossRefPubMedGoogle Scholar
  31. 31.
    M.M. Fernandez-Balsells, M.H. Murad, A. Barwise, J.F. Gallegos-Orozco, A. Paul, M.A. Lane, J.F. Lampropulos, I. Natividad, L. Perestelo-Pe ́rez, P.G. Ponce de Leo ́n-Lovato ́n et al.. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J. Clin. Endocrinol. Metab. 96, 905–912 (2011)CrossRefPubMedGoogle Scholar
  32. 32.
    G. Faglia, Epidemiology and pathogenesis of pituitary adenomas. Acta Endocrinol. 129(Suppl 1), 1–5 (1993)Google Scholar
  33. 33.
    W. Saeger, D.K. Lüdecke, M. Buchfelder, R. Fahlbusch, H.-J. Quabbe, S. Petersenn. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur. J. Endocrinol. 156, 203–216 (2007)Google Scholar
  34. 34.
    N. Karavitaki, G. Thanabalasingham, H.C. Shore et al.. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin. Endocrinol. 65, 524–529 (2006)CrossRefGoogle Scholar
  35. 35.
    F.F. Casanueva, M.E. Molitch, J.A. Schlechte et al.. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin. Endocrinol. 65, 265–273 (2006)CrossRefGoogle Scholar
  36. 36.
    S. Varshney, C. Gupta, K.K. Bansal, S.S. Bist, S. Bhagat, Endoscopic trans-nasal trans-sphenoidal (TNTS) approach for pituitary adenomas: our experience. Indian J. Otolaryngol. Head Neck Surg. 65(Suppl 2), 308–313 (2013)Google Scholar
  37. 37.
    P.U. Freda, A.M. Beckers, L. Katznelson, M.E. Molitch, V.M. Montori, K.D. Post, M.L. Vance, Pituitary incidentaloma: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 96(4), 894–904 (2011)CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Endocrinology and Metabolic Diseases Department, Internal Medicine IIIJena University HospitalJenaGermany
  2. 2.Private Practice for EndocrinologyAlexandroupolisGreece
  3. 3.Department of NeurosurgeryJena University HospitalJenaGermany

Personalised recommendations